28. Lace B, Sveger T, Krams A, Cernevska G, Krumina A. Age of SERPINA1 gene PI Z mutation: Swedish and Latvian population analysis. Ann Hum Genet. 2008;72(Pt 3):300–4. 29. Blanco I, EF Bustillo, MC Rodríguez. Distribution of a1-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysis. Clin Genet. 2001;60:431–44. 30. de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 2002;122:1818–29. 31. de Serres, F.J., I. Blanco, E.F. Bustillo. Genetic Epidemiology of Alpha-1 Antitrypsin Deficiency in Australia, Canada, New Zealand, and the United States of America. Clin Genet. 2003;64:1–16. 32. de Serres, F.J., I. Blanco, E.F. Bustillo. Health implications of alpha1-antitrypsin deficiency in Sub-Sahara African countries and their emigrants in Europe and the New World. Genet Med. 2005;7:175–84. 33. Gavhami S, Hashemi M, Shahriari HA, Bajestani SN, de Serres F, Moghaddam EM, Kamezi M, Alavian SM, Taheri M, Blanco I, Fernández-Bustillo E. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran. Clin Biochem. 2005;38:425–32. 34. de Serres FJ, Blanco I, Fernández-Bustillo E. Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia. Eur Respir J. 2006;28:1091–9. 35. de Serres FJ, Blanco I, Fernández-Bustillo E. Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America. Monaldi Arch Chest Dis. 2009;71:96–105. 36. Pérez-Rubio G, Jiménez-Valverde LO, Ramírez-Venegas A, Camarena Á, Sansores RH, Flores-Trujillo F, Reséndiz-Hernández JM, Falfán-Valencia R. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values. Arch Bronconeumol. 2015;51:80–5.
130